Spots Global Cancer Trial Database for immune response
Every month we try and update this database with for immune response cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Investigating and Characterizing the Immune Response to Prostate Cancer | NCT03331367 | Prostate Cancer | Blood draw Urine sample | 18 Years - | NYU Langone Health | |
| Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 | NCT03233828 | Melanoma (Skin) Melanoma in Sit... | Aldesleukin Saline | 18 Years - 80 Years | Nova Scotia Health Authority | |
| Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | NCT01890213 | Stage III Colon... | AVX701 | 18 Years - | Duke University | |
| Vaccination Against COVID-19 in Cancer | NCT04715438 | Cancer | mRNA-1273 SARS-... | 18 Years - | University Medical Center Groningen | |
| Immune Response in Lung Cancer | NCT01955343 | Lung Cancer | 18 Years - 80 Years | Lithuanian University of Health Sciences | ||
| A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. | NCT00199836 | Cancer Neoplasm | NY-ESO-1b pepti... | 18 Years - | Ludwig Institute for Cancer Research | |
| Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer | NCT01668849 | Head and Neck C... Oral Mucositis | Grape extract Lortab, Fentany... | 20 Years - 85 Years | University of Louisville | |
| Radio-Immuno-Modulation in Lung Cancer | NCT02579005 | Lung Cancer | Patients with a... Patients with a... | 18 Years - | Hopital du Sacre-Coeur de Montreal | |
| Immunomonitoring of Breast Cancer Patients During Systemic Treatment | NCT04925856 | Breast Cancer | blood sample | 18 Years - 85 Years | Centre Georges Francois Leclerc | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Immune Response in Lung Cancer | NCT01955343 | Lung Cancer | 18 Years - 80 Years | Lithuanian University of Health Sciences | ||
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Nutrition and Inflammation in Patients With Head and Neck Cancer | NCT03343236 | Head and Neck N... Radiotherapy Si... Inflammation Metabolism | Radiotherapy | 18 Years - | Uppsala University | |
| IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma | NCT01189383 | Malignant Melan... Malignant Melan... | IL15-DC Vaccine | 21 Years - 75 Years | Baylor Research Institute | |
| WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation | NCT01827137 | Multiple Myelom... Minimal Residua... High-Risk Cance... | WT1 Analog Pept... Sargramostim (G... lenalidomide | 18 Years - | Sellas Life Sciences Group | |
| Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) | NCT02179515 | Lung Cancer Breast Cancer Prostate Cancer Tumors (Others) Ovarian Cancer | MVA-brachyury- ... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas | NCT02364024 | Metastatic Colo... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | ||
| Radium-223 in Biochemically Recurrent Prostate Cancer | NCT04206319 | Biochemical Rec... | Radium-223 18F Sodium Fluo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection | NCT04645147 | EBV Epstein-Barr Vi... Infectious Mono... | EBV gp350-Ferri... Matrix-M1 | 18 Years - 29 Years | National Institutes of Health Clinical Center (CC) | |
| Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients | NCT04247464 | Fasting | Fasting | 18 Years - 75 Years | IMDEA Food | |
| Investigating and Characterizing the Immune Response to Prostate Cancer | NCT03331367 | Prostate Cancer | Blood draw Urine sample | 18 Years - | NYU Langone Health | |
| Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | NCT01890213 | Stage III Colon... | AVX701 | 18 Years - | Duke University | |
| NHS-IL12 for Solid Tumors | NCT01417546 | Epithelial Neop... Epithelial Tumo... Malignant Mesen... | NHS-IL-12 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cancer Vaccine Targeting Brachyury Protein in Tumors | NCT01519817 | Neoplasms Malignant Solid... Colon Neoplasms Adenocarcinoma | GI-6301 (Yeast ... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | NCT00103545 | Ovarian Cancer Fallopian Tube ... Peritoneal Neop... | ACA 125 | 0 Years - | AGO Study Group | |
| QUILT-3.006 for Recurrent Medullary Thyroid Cancer | NCT01856920 | Medullary Thyro... | GI-6207 [Recomb... | 18 Years - 100 Years | NantCell, Inc. | |
| Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | NCT03315871 | Prostate Cancer | PROSTVAC-V PROSTVAC-F MSB0011359C (M7... CV301 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| NHS-IL12 for Solid Tumors | NCT01417546 | Epithelial Neop... Epithelial Tumo... Malignant Mesen... | NHS-IL-12 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer | NCT03661047 | Colon Cancer | AMR101 (VASCEPA... | 18 Years - | Massachusetts General Hospital | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| NHS-IL12 for Solid Tumors | NCT01417546 | Epithelial Neop... Epithelial Tumo... Malignant Mesen... | NHS-IL-12 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer | NCT01668849 | Head and Neck C... Oral Mucositis | Grape extract Lortab, Fentany... | 20 Years - 85 Years | University of Louisville | |
| Immunological Response After Ablative Therapy in the Liver | NCT03040453 | Hepatocellular ... Immune Response | Microwave ablat... Irreversible el... | 18 Years - | Karolinska Institutet | |
| Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | NCT00243594 | Melanoma Stage ... | Peptide-pulsed ... | 18 Years - 75 Years | Radboud University Medical Center | |
| Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer | NCT03724994 | Periampullary A... Periampullary C... Pancreatic Canc... | Gemcitabine | 18 Years - | Lund University | |
| Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant | NCT02947854 | Healthy Volunte... | Fimaporfin (Pho... Hiltonol (Poly-... HPV E7 (Human P... KLH (Keyhole Li... | 18 Years - 55 Years | PCI Biotech AS | |
| Nutrition and Inflammation in Patients With Head and Neck Cancer | NCT03343236 | Head and Neck N... Radiotherapy Si... Inflammation Metabolism | Radiotherapy | 18 Years - | Uppsala University | |
| Role of Immunoscore® in Stage II-III Colorectal Cancer | NCT05422547 | Colon Adenocarc... | Immunoscore Col... | - | D'Or Institute for Research and Education | |
| Investigating and Characterizing the Immune Response to Prostate Cancer | NCT03331367 | Prostate Cancer | Blood draw Urine sample | 18 Years - | NYU Langone Health | |
| Vaccination Against COVID-19 in Cancer | NCT04715438 | Cancer | mRNA-1273 SARS-... | 18 Years - | University Medical Center Groningen | |
| SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients | NCT05313074 | COVID-19 Cancer | CoronaVac vacci... | 18 Years - | National Cancer Institute, Thailand | |
| A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. | NCT00199836 | Cancer Neoplasm | NY-ESO-1b pepti... | 18 Years - | Ludwig Institute for Cancer Research | |
| Vaccination Against COVID-19 in Cancer | NCT04715438 | Cancer | mRNA-1273 SARS-... | 18 Years - | University Medical Center Groningen | |
| Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) | NCT02179515 | Lung Cancer Breast Cancer Prostate Cancer Tumors (Others) Ovarian Cancer | MVA-brachyury- ... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers | NCT02979470 | Colon Cancer St... Rectum Cancer, ... Colon Cancer St... Colon Cancer St... Colon Cancer St... | 18 Years - 70 Years | AC Camargo Cancer Center | ||
| Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 | NCT03233828 | Melanoma (Skin) Melanoma in Sit... | Aldesleukin Saline | 18 Years - 80 Years | Nova Scotia Health Authority |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
